MRNA FUND II LP 4
4 · SIRNA THERAPEUTICS INC · Filed Nov 20, 2003
Insider Transaction Report
Form 4
MRNA FUND II LP
10% Owner
Transactions
- Sale
Common Stock
2003-11-18$6.21/sh−7,921$49,189→ 3,768,737 total(indirect: By Oxford Bioscience Partners IV L.P.) - Sale
Common Stock
2003-11-18$6.21/sh−79$491→ 37,815 total
Footnotes (1)
- [F1]The reporting person shares a common general partner with the partnership that owns the reported securities. The reporting person disclaims beneficial ownership of the reported securities.